Stevens J Company Profile
✉ Email this page to a colleague
What is the competitive landscape for STEVENS J, and what generic and branded alternatives to STEVENS J drugs are available?
STEVENS J has twelve approved drugs.
Summary for Stevens J
| US Patents: | 0 |
| Tradenames: | 11 |
| Ingredients: | 11 |
| NDAs: | 12 |
Drugs and US Patents for Stevens J
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stevens J | DEFERASIROX | deferasirox | TABLET;ORAL | 210727-002 | Dec 27, 2019 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Stevens J | DEFERASIROX | deferasirox | TABLET;ORAL | 210727-003 | Jun 15, 2020 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Stevens J | CINACALCET HYDROCHLORIDE | cinacalcet hydrochloride | TABLET;ORAL | 204364-002 | Dec 2, 2021 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Stevens J | DEFERASIROX | deferasirox | TABLET;ORAL | 210727-001 | Dec 27, 2019 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
